Realcan Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China
瑞康医药
No insider purchase over the last 90 days. The latest, by 烟台慧投投资发展合伙企业(有限合伙), was filed 21 Jun 2024.
Realcan Pharmaceutical Group Co., Ltd.: what insiders have been doing
Every trade that managers of Realcan Pharmaceutical Group Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Realcan Pharmaceutical Group Co., Ltd. in twelve months, the latest record being from 21 June 2024.
The full history, which starts in 2022, counts 1 purchase against 5 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +34.3%Entry CN¥2.16 · Close at T+365 CN¥2.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,638,600 shares100.0% of flowA股XSHESZSE:173000007779437440Canonical exit: 19 Sept 2024 (T+90)
- 15,000,000 shares27.2% of flowA股XSHESZSE:173000006588598820
- 13,040,000 shares23.5% of flowA股XSHESZSE:173000006420235800
- 2,000,000 shares100.0% of flowA股XSHESZSE:173000006420235900
- 8,000,000 shares16.1% of flowA股XSHESZSE:173000005952608930
- 16,000,000 shares33.2% of flowA股XSHESZSE:173000006591157250
6 of 6 declarations
About Realcan Pharmaceutical Group Co., Ltd.
瑞康医药 is a company specializing in the healthcare and pharmaceutical sector, providing products and services related to health care. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
